NasdaqGM:ATAIPharmaceuticals
Is It Time To Reassess AtaiBeckley (NasdaqGM:ATAI) After Its 188.7% One-Year Surge?
If you are trying to figure out whether AtaiBeckley is priced attractively or getting ahead of itself, the recent share performance gives a useful starting point.
The stock closed at US$4.33, with returns of 27.4% over the last 30 days, 11.9% year to date and 188.7% over the past year, although the last 7 days show an 8.1% decline.
Recent coverage around AtaiBeckley has focused on how the stock fits into the broader Pharmaceuticals space and what that means for risk and reward today. This...